CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.

MLA

Suh, Sang Heon, et al. “CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.” International Journal of Molecular Sciences, vol. 21, no. 4, Feb. 2020, p. 1473. EBSCOhost, https://doi.org/10.3390/ijms21041473.

APA

Suh, S. H., Choi, H. S., Kim, C. S., Kim, I. J., Cha, H., Cho, J. M., Ma, S. K., Kim, S. W., & Bae, E. H. (2020). CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome. International Journal of Molecular Sciences, 21(4), 1473. https://doi.org/10.3390/ijms21041473

Chicago

Suh, Sang Heon, Hong Sang Choi, Chang Seong Kim, In Jin Kim, Hyunju Cha, Joong Myung Cho, Seong Kwon Ma, Soo Wan Kim, and Eun Hui Bae. 2020. “CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.” International Journal of Molecular Sciences 21 (4): 1473. doi:10.3390/ijms21041473.